Evidence map›Paper›PMID 34831595›Full record

ArticleInternational journal of environmental research and public health2021

Environmental Substances Associated with Alzheimer's Disease-A Scoping Review.

Hanna Maria Elonheimo, Helle Raun Andersen, Andromachi Katsonouri, Hanna Tolonen

Open access · goldAbstract readScoping Review
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Metals in Alzheimer's Disease.Biomedicines · 2023
    Review
  9. Article
  10. Alzheimer's Disease Association with Metals and Metalloids Concentration in Blood and Urine.International journal of environmental research and public health · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Hanna Maria ElonheimoDepartment of Public Health and Welfare, Finnish Institute for Health and Welfare (THL), Mannerheimintie 166, 00271 Helsinki, Finland.ORCID 0000-0003-4441-3432
Helle Raun AndersenClinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, DK-5000 Odense C, Denmark.ORCID 0000-0002-9184-3593
Andromachi KatsonouriHuman Biomonitoring and Control of Industrial Products Laboratory, State General Laboratory, Ministry of Health, P.O. Box 28648, Nicosia 2081, Cyprus.ORCID 0000-0003-2038-0648
Hanna TolonenDepartment of Public Health and Welfare, Finnish Institute for Health and Welfare (THL), Mannerheimintie 166, 00271 Helsinki, Finland.ORCID 0000-0003-3121-4303
Finnish Institute for Health and Welfare · FIMinistry of Health · CYUniversity of Southern Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is the most common form of dementia, prevalent in approximately 50-70% of the dementia cases. AD affects memory, and it is a progressive disease interfering with cognitive abilities, behaviour and functioning of the person affected. In 2015, there were 47 million people affected by dementia worldwide, and the figure was estimated to increase to 75 million in 2030 and to 132 million by 2050. In the framework of European Human Biomonitoring Initiative (HBM4EU), 18 substances or substance groups were prioritized for investigation. For each of the priority substances, a scoping document was prepared. Based on these scoping documents and complementary review of the recent literature, a scoping review of HBM4EU-priority substances which might be associated with AD was conducted. A possible association between risk of AD and pesticides was detected. For mercury (Hg), association is possible but inconsistent. Regarding cadmium (Cd) and arsenic (As), the results are inconsistent but inclined towards possible associations between the substances and the risk of disease. The evidence regarding lead (Pb) was weaker than for the other substances; however, possible associations exist. Although there is evidence of adverse neurological effects of environmental substances, more research is needed. Environmental chemical exposure and the related hazards are essential concerns for public health, and they could be preventable.

Indexed as

Alzheimer DiseaseArsenicMercuryBiological MonitoringCadmiumEnvironmental ExposureEnvironmental MonitoringHumansArsenicCadmiumMercuryAlzheimer’s disease (AD)arsenic (As)cadmium (Cd)chemical exposureHBM4EUlead (Pb)mercury (Hg)pesticides

Identifiers

PMID34831595
PMCPMC8622417
OpenAlexW3213795772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.